Story · Medicine & Biotech
STAT+: FDA approves new breast cancer drug, providing new option for some patients, boost for Roche
1 outlet · first reported by STAT News on
The Food and Drug Administration on Monday approved a new breast cancer drug from Roche, teeing up the launch of a medicine that the Swiss company has said could become its top-selling product ever. The approval of Wilserdly, also known as giredestrant, was one of the most important regulatory… (STAT News)
Coverage, in order
-
STAT+: FDA approves new breast cancer drug, providing new option for some patients, boost for RocheThe Food and Drug Administration on Monday approved a new breast cancer drug from Roche, teeing up the launch of a medicine that the Swiss company has said could become its top-selling product ever. The approval of Wilserdly, also known as giredestrant, was one of the most important regulatory…
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.